Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 1:44 AM
Ignite Modification Date:
2025-12-26 @ 12:01 AM
NCT ID:
NCT04173494
Group ID:
EG003
Title:
DAN 300 mg BID to MMB 200 mg QD- Open-Label Extended Treatment Period
Description:
Participants who completed the randomized treatment period, discontinued treatment early due to splenic progression, or discontinued treatment early for other reasons but completed scheduled assessments through Week 24 were enrolled in an open-label extended treatment period. Participants who received DAN 300 mg BID during randomized period switched to receive 200 mg of MMB orally QD during open-label extended treatment period.
Deaths Number Affected:
8
Deaths Number At Risk:
None
Serious Number Affected:
12
Serious Number At Risk:
41
Other Number Affected:
28
Other Number At Risk:
41
Study:
NCT04173494
Results Section:
NCT04173494
Adverse Events Module:
NCT04173494